Global /China /Healthcare /Biotechnology /688276

Changchun BCHT Biotechnology Co.

688276

• SSE: 688276 • Delayed

18.17CNY 0.2%

2.68 USD

As of 14 June 2026, Changchun BCHT Biotechnology Co. has a market cap of $1.11B USD, ranking #10144 globally and #2805 in China. It ranks #890 in the Healthcare sector, and #164 in the Biotechnology industry.

Global Rank

10144

Country Rank

2805

Sector Rank

890

Industry Rank

164

Key Stats

Market Cap

$1.11BUSD

7.5B CNY

Enterprise Value

$1.13BUSD

7.62B CNY

Revenue (TTM)

$87.09MUSD

590.13M CNY

EBITDA (TTM)

-$11.11MUSD

-75.17M CNY

Net Income (TTM)

-$39.42MUSD

-267.12M CNY

EBITDA Margin

-13%

Profit Margin

-45%

PS Ratio

12.7

PB Ratio

2.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Chunlai Jiang open_in_new

Employees

1,266

Founded

2004

Website

bchtpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	2.5%	1.5%	-11%	-17%	-3.7%	-11%	-74%	-88%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688276 长春百克生物科技股份公司 Ordinary Shares - Class A ISIN: CNE100005XY6 Shares Out.: Shares Outstanding: 413.658M¹ Shares Float: 95.521M² TV: TradingView: SSE: 688276 SA: Stock Analysis: SHA: 688276 YF: Yahoo Finance: 688276.SS GF: Google Finance: SHA: 688276 BA: Barron's: 688276 MS: Morningstar: XSHG: 688276	18.17 CNY	TV: TradingView: SSE: 688276 SA: Stock Analysis: SHA: 688276 YF: Yahoo Finance: 688276.SS GF: Google Finance: SHA: 688276 BA: Barron's: 688276 MS: Morningstar: XSHG: 688276

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 1K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 1K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 623%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 563%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 540%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 507%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 16K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 14K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 4K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 4K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 4K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 4K%	37.2	Switzerland

chevron_leftBack